[Structured introduction of new drug therapies: valuable initiative--transparency required].
Lundkvist
Jonas
J
Novartis Sverige AB. jonas.lundkvist@novartis.com
Henriksson
Freddie
F
D035843:Biomedical Research; D004059:Diffusion of Innovation; D016527:Drug Costs; D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods*; D004345:Drug Industry; D015507:Drugs, Investigational / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D011358:Product Surveillance, Postmarketing
D015507:Drugs, Investigational